AU2003282512A1 - Methods of reducing the activity of and reducing the concentration of a mutant kit protein - Google Patents

Methods of reducing the activity of and reducing the concentration of a mutant kit protein

Info

Publication number
AU2003282512A1
AU2003282512A1 AU2003282512A AU2003282512A AU2003282512A1 AU 2003282512 A1 AU2003282512 A1 AU 2003282512A1 AU 2003282512 A AU2003282512 A AU 2003282512A AU 2003282512 A AU2003282512 A AU 2003282512A AU 2003282512 A1 AU2003282512 A1 AU 2003282512A1
Authority
AU
Australia
Prior art keywords
reducing
activity
concentration
methods
kit protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003282512A
Other versions
AU2003282512A8 (en
Inventor
Gerard Fumo
Len Neckers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2003282512A8 publication Critical patent/AU2003282512A8/en
Publication of AU2003282512A1 publication Critical patent/AU2003282512A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
AU2003282512A 2002-10-22 2003-10-08 Methods of reducing the activity of and reducing the concentration of a mutant kit protein Abandoned AU2003282512A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42014302P 2002-10-22 2002-10-22
US60/420,143 2002-10-22
PCT/US2003/031962 WO2004037978A2 (en) 2002-10-22 2003-10-08 Methods of reducing the activity of and reducing the concentration of a mutant kit protein

Publications (2)

Publication Number Publication Date
AU2003282512A8 AU2003282512A8 (en) 2004-05-13
AU2003282512A1 true AU2003282512A1 (en) 2004-05-13

Family

ID=32176520

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003282512A Abandoned AU2003282512A1 (en) 2002-10-22 2003-10-08 Methods of reducing the activity of and reducing the concentration of a mutant kit protein

Country Status (2)

Country Link
AU (1) AU2003282512A1 (en)
WO (1) WO2004037978A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200922595A (en) * 2007-10-12 2009-06-01 Novartis Ag Organic compounds
EP2252595B1 (en) 2008-02-01 2014-03-26 Takeda Pharmaceutical Company Limited Oxim derivatives as hsp90 inhibitors

Also Published As

Publication number Publication date
AU2003282512A8 (en) 2004-05-13
WO2004037978A3 (en) 2006-06-15
WO2004037978A2 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU2003288902A1 (en) Microcapsules and methods of use
AU2003217870A1 (en) Pini-modulating compounds and methods of use thereof
AU2003225669A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003300021A1 (en) Thiosemicarbazones as anti-virals and immunopotentiators
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2003278832A1 (en) Optical biosensors and methods of use thereof
AU2003256703A1 (en) Biosensor arrays and methods
AU2002310008A1 (en) Composition with enhance cetylpyridinium chloride activity and method of using the same
AU2003239355A1 (en) Single pass sequencing assembly and method
AU2003297037A1 (en) Illuminant and method
AU2003243660A1 (en) Coordinating flooring and methods
AU2003215244A1 (en) Complexes and methods of using same
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003297612A1 (en) 2-substituted-3-propenamide derivatives and methods of using the same
AU2003282512A1 (en) Methods of reducing the activity of and reducing the concentration of a mutant kit protein
AU2003284597A1 (en) Apoptosis-associated protein and use thereof
AU2003222533A1 (en) Proteins with deglycating activities and methods of using same
AU2003273362A1 (en) Scrubber and method of using scrubber
AU2003274437A1 (en) Method of ameliorating vision-inhibiting effects of cataracts and the like
AU2003220085A1 (en) Protein a compositions and methods of use
WO2005042707A9 (en) Taspasel 1 and methods of use
AU2003228597A1 (en) ANTIBODIES FOR ENZYMES OF THE Omega-OXIDATION PATHWAY AND METHODS RELATING THERETO

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase